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Abstract
Wound healing occurs by a series of interrelated molecular events which work together
to  restore  tissue  integrity  and  cellular  function.  These  physiological  events  occur
smoothly in normal healthy individual and/or under normal conditions. However, in
certain cases, these molecular events are retarded resulting in hard-to-heal or chronic
wounds arising from several factors such as poor venous return, underlying physio-
logical or metabolic conditions such as diabetes as well as external factors such as poor
nutrition.  In  most  cases,  such  wounds  are  infected  and infection  also  presents  as
another complicating phenomenon which triggers inflammatory reactions, therefore
delaying wound healing.  There  has  therefore  been recent  interests  and significant
efforts  in  preventing  and  actively  treating  wound  infections  by  directly  targeting
infection causative agents through direct  application of antimicrobial  agents either
alone or loaded into dressings (medicated). These have the advantage of overcoming
challenges  such  as  poor  circulation  in  diabetic  and leg  ulcers  when administered
systemically and also require lower amounts to be applied compared to that required
via oral or iv administration. This chapter will review and evaluate various antimicro-
bial agents used to target infected wounds, the means of delivery, and current state of
the art, including commercially available dressings. Data sources will include mainly
peer-reviewed literature,  clinical  trials  and reports,  patents  as  well  as  government
reports where available.
Keywords: antimicrobial, bioburden, dressings, infection, wounds, wound healing,
bacterial resistance
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1. Introduction
A wound may be defined as a disruption to the physiological arrangement of the skin cells
and a disturbance to its function in connecting and protecting underlying tissues and organs.
It may be primary caused by accidental cut, tear, scratch, pressure, extreme temperatures,
chemicals, and electrical current, or secondary to surgical intervention or disease (i.e., diabetes,
ulcers,  or  carcinomas)  [1].  It  ranges from superficial  (affecting the epidermis)  to  partial-
thickness (affecting both epidermis and parts of the dermis) and full-thickness (including
subcutaneous fat and bones) wounds [2]. Wound healing is a physiological process, by which
the living body repairs tissue damages,  restores its  anatomical integrity,  and regains the
functionality of the injured parts. A wound can be closed by primary intention or left to heal
by secondary intention, and in both ways the healing process occurs through a series of
overlapping events and is influenced by a number of intrinsic and extrinsic factors [3].
1.1. Acute wounds
Acute wounds can heal within a limited amount of time, usually show no complications, and
are characterized by the loss of skin integrity (injury) that occurs suddenly. The injured tissue
heals in a predictable manner where platelets, keratinocytes, immune surveillance cells,
microvascular cells, and fibroblasts play major roles in the restoration of tissue integrity [4].
These wounds are either surgical or traumatic [5].
1.2. Chronic wounds
Chronic wounds are wounds that do not heal within normal period and are associated with
predisposing factors that weaken the integrity of dermal and epidermal tissues. Those factors
either disrupt the balance between wound bioburden and the patient’s immune system or
impair the wound healing cycle. In terms of duration, if the wound fails to heal or shows no
sign of recovery within 12 weeks, it is considered a chronic wound. Predisposing factors may
affect the tissue perfusion causing chronic wounds such as vascular ulcers, associated with
metabolic disorders such as diabetes causing diabetic foot ulcers [6]. They can be identified by
criteria such as delayed healing and friable granulation tissue, prolonged inflammatory phase,
persistent infection, and presence of resistant microorganisms [7–10].
1.3. Wound healing
The repair (wound healing) process involves four overlapping biochemical, physiological, and
molecular phases.
I. Hemostasis
This stage is characterized by microvascular injury and release of blood compo-
nents at the wound site. Platelets come into contact with and adhere to the wall of
the injured blood vessels. This adherence activates the platelets to release cyto-
kines, growth factors, and numerous pro-inflammatory mediators, resulting in
platelet aggregation and triggering the intrinsic and extrinsic coagulation path-
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ways to form a fibrin clot which limits further blood loss. Growth factors produced
by the platelets initiate the healing cascade [11, 12].
II. Inflammatory phase
The inflammatory phase starts at the same time as hemostasis sometime between
a few minutes after injury up to 24 h and lasts for about 3 days. Aggregated
platelets store vasoactive amines such as prostaglandins and histamine while other
amines from granules released by mast cells, in response to injury, result in
increased microvascular permeability and vasodilation, leading to exudation of
fluid into the extravascular space [13]. This allows the migration of monocytes and
protein-rich exudate into the wound and surrounding tissue, resulting in edema.
These are typical signs of the inflammation process, and patients start complaining
about pain at the site of injury within 24 h.
III. Proliferative phase
This phase commences after the inflammatory phase wanes. The remaining
inflammatory cells produce growth factors to initiate angiogenesis, which is
important to keep adequate blood supply within the wound bed [14]. Newly
formed blood vessels will contribute to granulation tissue (composed of collagen
and extracellular matrix) formation and provide the required nutrients.
IV. Maturation phase
This commences when the wound is superficially sealed. It involves the re-
epithelialization and remodeling of newly formed tissues in the proliferative
phase and restoration of epidermal integrity [15]. It also involves transferring
collagen III to collagen I.
1.4. Factors affecting wound healing
Multiple factors affect wound healing and lead to the impairment of healing classified into
local and systemic factors [16].
1.4.1. Oxygenation
Oxygen is crucial to wound healing and for resistance to infection, and used for cellular energy
production by adenosine triphosphate [17]. It acts on different levels of wound healing by
inducing angiogenesis, keratinocytes differentiation, migration, re-epithelialization, fibroblast
proliferation, and collagen synthesis, and promotes wound contraction [18]. When injury
occurs, temporary hypoxia and oxygen are useful to trigger wound healing by inducing the
production of cytokines and growth factors from macrophages, keratinocytes, and fibroblasts
[16]. Chronic wounds are generally hypoxic with oxygen tissue tension of 5–20 mm Hg
compared to normal levels of 30–50 mm Hg [19]. Factors predisposing chronic wounds such
as advancing age and diabetes can induce poor oxygenation through impaired vascular flow.
Interventional revascularization therapies have been used to reverse hypoxic conditions in
diabetic foot ulcers [20]. However, it has also been reported that such procedures can cause
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adverse effects to diabetic patients [21]. Recently, some topical foam dressings containing
dissolved oxygen were developed to increase oxygen perfusion into the chronic wound area
[22]. Results showed that dissolved oxygen from topical foam dressing penetrates into skin
layers compared to topical gaseous oxygen.
1.4.2. Wound bioburden and infection
1.4.2.1. Bioburden
The intact skin acts to control the microbial population on the skin surface itself [23]. Once the
integrity is lost through injury, the subcutaneous tissue becomes exposed, providing an
environment for colonization and growth of microbes. However, this does not necessarily lead
to an infection as there is a balance between the wound bioburden and the immune system [24].
1.4.2.2. Wound infection
Skin microflora is present to about 105 colonies without any clinical problems [25]. However,
if the balance is disrupted, microorganisms will proliferate and start a microbiological chain
of events by invading tissues resulting in an inflammatory response which may lead to tissue
damage and delayed healing [7]. Once it causes damage to the host tissue, infection will arise.
One of the consequences of infection is the prolonged inflammation due to prolonged elevation
of pro-inflammatory cytokines, which causes the wound to enter the chronic stage and fail to
heal within the expected 8–12 weeks [26]. This prolonged inflammation is also associated with
increased levels of matrix metalloproteases which are capable of degrading the extracellular
matrix which is the key component of proliferative phase of wound healing [9]. This increase
in protease levels happens at the expense of the naturally occurring protease inhibitor levels
that are decreased. From a microbiological perspective, wound infection is described as the
presence of replicating microorganisms at the wound site overwhelming the host’s immune
system. It delays wound healing due to the release of toxins and exhibits active signs and
symptoms of infections.
1.4.2.3. Common bacterial species present in chronic wounds
Generally, most infected wounds are polymicrobial and are commonly contaminated by
pathogens found in the immediate environment, the endogenous microbes living in the
mucous membranes, and the microflora on adjacent skin. Bacteria are the main cause of wound
infection among other microorganisms present in the skin, though other microorganisms such
as fungi have been implicated in certain mixed infections. In the initial stages of chronic wound
formation, Gram-positive organisms such as Staphylococcus aureus and Escherichia coli are
predominant [9]. In the later stages, Gram-negative Pseudomonas species are common and tend
to invade deeper layers in the wound causing significant tissue damage [27]. Other aerobes
implicated include Staphylococci and Streptococci species as well as anaerobic bacteria and are
estimated in 50% of chronic wounds [28, 29].
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1.4.3. Chronic wounds and biofilm
Biofilm is defined as “a microbially derived sessile community characterized by cells that are
irreversibly attached to a substratum or interface or to each other, are embedded in a secreted
matrix of extracellular polymeric substances (EPSs), and exhibit an altered phenotype with
respect to growth rate and gene transcription” [30]. Firstly, conditioning film forms and is
composed of proteins and polysaccharide molecules adsorbed onto the solid surface. This
makes the surface ready to receive the first cells of the insipient biofilm. Secondly, bacteria will
start to approach and attach onto the surface by forces such as van der Waals forces and the
negative electrostatic charges of bacterial surface [31]. The attached bacteria become encased
in a polymeric matrix called extracellular polymeric substance (EPS). This bacterial attachment
induces a phenomenon called quorum sensing, which is responsible for “the regulation of gene
expression in response to fluctuations in cell population density” [32]. This causes the bacteria
within biofilm to alter their phenotypes resulting in the production of more virulent factors in
response to signals from other bacteria within biofilm. These factors with barrier made from
EPS contribute to the increased resistance to antibiotics. It has been suggested that EPS can
interact with antibiotics spontaneously thereby preventing them reaching the bacteria to exert
their antimicrobial activity [33]. The biofilm also protects the bacteria from host defenses by
the covering of glycocalyx while bacteria secrete products within the film which makes
phagocytic penetration poor [34].
This understanding is of great importance for intervention modalities in chronic wounds
especially the use of antimicrobial wound dressing. For example macrolides can have inhibi-
tory effect on the film formation or induce phagocytic invasion into biofilms [35]. Furthermore,
in clinical wound management, it is always essential to promptly clean the wound and remove
necrotic tissue and foreign material (e.g. bacteria and biofilms) from areas around the wound
to improve the chances of enhanced wound healing, and this is known as debridement [1].
This is important because the presence of necrotic tissue increases the risk of infection and
sepsis, which prolongs the inflammatory phase. Several approaches are employed including
surgical removal, wound irrigation (e.g. saline and antiseptics such as chlorhexidine), autolytic
rehydration using hydrogel dressings, applying enzymes such as collagenases or streptokinase
preparations as well as using maggots to selectively dissolve necrotic and infected tissue
(including biofilms) without destroying healthy or newly formed tissue [1].
2. Wound dressings
Wound dressings can maintain a moist environment in the wound which helps in proliferation
and migration of fibroblast and keratinocytes. Moisture in the wound serves as a transporter
for enzymes, growth factors, and hormones, thus inducing cell growth. Moist wound dressings
promote collagen synthesis and decrease scar formation [36] which help wounds to heal faster
[37]. Modern moist wound dressings can be classified depending on their materials (synthetic
and natural polymers) and physical forms (hydrogels, hydrocolloids, films, and wafers).
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Hydrogels consist of hydrated polymers which make them hydrophilic in nature. Water
content is higher than 95%, and as a result they cannot absorb much exudate and cause
maceration. But, this dressing is very useful in dry wound which can maintain moisture
within wounds [36]. A Cochrane Review [38] of hydrogel dressings for healing diabetic foot
ulcers suggests that hydrogel dressings are more effective than basic wound contact dressing.
Hydrogels have advantages of autolytic debridement of slough and necrotic tissue and do
not support bacterial growth [39, 40]. Hydrocolloid dressings are occlusive and can absorb
wound exudate into the matrix to help improve healing. It can work for a sustained period
of time, thus reducing the frequency of dressing changes. It also assists autolysis of necrotic
materials [40]. Due to its extra absorbent nature, it is widely used in the treatment of cavity
wounds [41]. A Cochrane Review [42] reported that any type of hydrocolloid and other
dressings have no difference in efficacy. Foam dressings are highly absorptive, protective, and
comfortable to the body surface. They promote thermal insulation, angiogenesis, and
autolysis [43]. Film dressings are adhesive, transparent, durable, comfortable, and cost
effective. Due to their transparency, the wound bed can be monitored without removing the
dressing. However, films are suitable for superficial pressure wounds. The disadvantage of
film dressing is maceration of wound exudate [36]. Lyophilized wafers are one of the most
recent moist dressings proposed for wound care. Due to their highly porous nature, they can
absorb high amounts of exudate rapidly which improves wound healing. Wafers can carry
both antibacterial and anti-inflammatory drugs at the same time which give dual effects of
inhibiting bacteria and reducing inflammation [44]. Wafers have good adhesion and diffusion
properties [45] while Labovitiadi et al. [46] reported that wafers are a compatible delivery
system for both insoluble and soluble antimicrobial drugs that exhibit better antimicrobial
activity.
3. Antimicrobial wound dressings
3.1. Need for antimicrobial wound dressing
The major need for antimicrobial dressing is drug resistance to bacteria. Zubair et al. [47]
isolated bacteria from diabetic foot ulcer patients and their resistance to different classes of
drugs with the penicillins showing highest susceptibility to resistance followed by cephalo-
sporins (54%), quinolones and fluoroquinolones (52.8%), aminoglycosides (38.5%), beta
lactams (32.2%), and carbapenems (18.4%). Further, most chronic wound sufferers such as
older patients and diabetics with leg and foot ulcers suffer from complications of poor
circulation at the lower extremities, which makes oral and IV antibiotics ineffective. In addition,
topical dressings are able to avoid the adverse effects of systemic administration (oral and IV)
of high antibiotic doses including nausea, vomiting, diarrhea, allergic reactions, leukocyturia,
insomnia, headache, and vaginosis, when only small doses above the minimum inhibitory
concentration are required at the infected wound site. Finally, production costs of most
dressings are less than those of IV or oral products.
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3.2. Advanced medicated antimicrobial wound dressings
Antimicrobial dressings can be broadly classified into two groups as antiseptic or antibiotic
dressings. Antiseptic dressings have broad spectrum activity which can kill or inhibit bacteria,
fungus, protozoa, viruses, and prions [48]; however, some antiseptic dressings often show
dose-dependent cytotoxicity to the host cells including keratinocytes, fibroblasts, and leuko-
cytes [49, 50]. The concentration of povidone iodine greater than 0.004 and 0.05% is completely
toxic to keratinocytes and fibroblasts, respectively [51]. Cadexomer iodine is reported to be
nontoxic to fibroblasts in vitro at concentrations of up to 0.45% [52]. Chlorhexidine also shows
dose-dependent toxicity to fibroblasts at concentrations between 0.2 and 0.001% [53, 54].
Moreover, silver-impregnated dressings have been reported to be more cytotoxic to epidermal
keratinocytes and dermal fibroblasts than honey-based dressings [55]. On the other hand,
Dressing type Polymers Drug Reference
Pads Bovine serum albumin Ciprofloxacin [58]
Nanofibers patch PVA/sodium alginate Ciprofloxacin [59]
Hydrogel Polyethylene glycol Ciprofloxacin [60]
Sponges Alginate/chitosan Ciprofloxacin [61]
Films Chitosan/gelatin Ciprofloxacin [62]
Nanofibers PVA/regenerated silk fibroin Ciprofloxacin [63]
Nanofiber mats Polyurethane/dextran Ciprofloxacin [64]
Nanofiber mats PVA/poly(vinyl acetate) Ciprofloxacin [65]
Films Poly (2-hydroxymethacrylate) Ciprofloxacin [66]
Films PVA/aminophenylboronic acid Ciprofloxacin [67]
Collagen dressing Collagen Ciprofloxacin [68]
Hydrogels Keratin Ciprofloxacin [69]
Films Sodium carboxymethyl cellulose/gelatin Ciprofloxacin [70]
Scaffolds Chitosan/polyethylene glycol Ciprofloxacin [71]
Hydrogel films Carboxymethyl chitin Chlorhexidine gluconate [72]
Gel Chitosan Ofloxacin [73]
Wafers and films Polyox/carrageenan Streptomycin [74–76]
Films PVA/sodium alginate Clindamycin and nitrofurazone [77, 78]
Films PVA/dextran Gentamicin [79]
Scaffolds Collagen Doxycycline [80]
Microspheres Gelatin Doxycycline [81]
Microspheres Chitosan Levofloxacin [82]
Nanofibrous scaffolds Chitosan/poly(e-caprolactone) Levofloxacin [82]
Hydrogels Polyvinylalcohol Nitric oxide [83]
Hydrogels poly(2-hydroxyethyl methacrylate) Nitric oxide [84]
Hydrogels S-Nitrosothiol Nitric acid [85]
Table 1. Summary of antibiotic dressings reported in the literature.
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antibiotic dressings (Table 1) are nontoxic and can work effectively on the target sites without
damaging host tissues [49]. The ideal antimicrobial dressing should have broad spectrum
activity against all major microorganisms, be nonallergic and nontoxic to host cells, have the
ability to drain exudate and maintain a moist wound environment, should release drugs
rapidly in a sustained manner, should reduce malodor, and be cost effective [56, 57].
3.3. Silver-based dressings
Silver is a natural broad spectrum antibiotic, and its dressings have not yet shown any bacterial
resistance. Silver exists in different forms such as silver oxide, silver nitrate, silver sulfate, silver
salt, silver zeolite, silver sulfadiazine (SSD), and silver nanoparticles (AgNPs). Before the
eighteenth century, silver nitrate was used for leg ulcers, epilepsy, acne, and venereal infec-
tions [86]. Currently different forms of silver are widely used in acute wound (burns, partial-
thickness burns, freshly grafted burns, second-degree burns, surgical/traumatic wounds,
colorectal surgical wounds, pilonidal sinus, and donor site), and chronic wound (pressure
ulcers, leg ulcers, and diabetic foot ulcers) healing [87].
3.3.1. Antimicrobial activity of silver dressings
Antimicrobial activity of silver dressings depends on the amount and rate of silver release and
its toxicity to bacterial, fungal, and algal cells. Silver works by interacting with thiol groups
present in bacterial cells thus stop their respiration process. In the case of E. coli, silver prevents
phosphate uptake and catalysation of disulfide bonds with silver tending to change the nature
of protein structure in E. coli. The degenerative changes in cytosolic protein cause cell death
[86, 88]. Feng et al. [89] reported antibacterial mechanism of action of silver ions on E. coli and
S. aureus and showed that silver ions penetrate into bacterial cells and condense DNA mole-
cules which inhibit their replication capabilities leading to cell death. Matsumura et al. [90]
introduced two bactericidal mechanism actions of silver zeolite on E. coli. Firstly, silver ions
released from silver zeolite come into contact with cells and penetrate into cells, altering the
cellular functions that cause cell death. Secondly, silver ions inhibit respiration process through
the generation of reactive oxygen molecules. Silver zeolite has also been reported against oral
microorganisms (Streptococcus mutans, Lactobacillus casei, Candida albicans, and S. aureus) [91].
Silver nanoparticles show the most efficient antimicrobial activity amongst all forms of silver.
The bactericidal effects of AgNPs depend on the size, shape, surface characteristics, and their
dose [88, 92–101]. It has been reported that 75 μg ml−1 of AgNPs having 1–100 nm particle size
inhibits all bacterial strains (specifically, E. coli, Vibrio cholerae, Salmonella typhi, and Pseudomonas
aeruginosa). It has also been reported nanoparticles having particle size ∼1–10 nm have higher
affinity of attaching to the surface of the cell membrane as compared to larger nanoparticles.
Because of this nature, AgNPs can attach to the larger surface area of bacterial cell membrane
and cause native membrane porations which cause cell damage [92]. Ivask et al. [93] examined
toxicity of silver nanoparticles to bacteria (E. coli), yeast (Saccharomyces cerevisiae), algae
(Pseudokirchneriella subcapitata), crustacean (Daphnia magna), and mammalian cells (murine
fibroblast) according to their particle sizes ranging from 10 to 80 nm. They confirmed that the
smaller-sized nanoparticles showed highly toxic effect. The review of Rai et al. [88] and Rizzello
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et al. [92] explained that truncated triangular nanoparticles are the strongest biocidal active
products compared to spherical- and rod-shaped nanoparticles. 1 μg of truncated triangular
nanoparticles shows greater activity than 12.5 μg of spherical-shaped nanoparticles and 50–
100 μg of rod-shaped nanoparticles due to the enhancement of electrostatic interaction with
bacterial cells (Table 2).
Dressing type Brand name Silver form
Contact layer dressings Restore contact layer Silver sulfate
Acticoat Flex 3; Acticoat Flex 7 Elemental silver
KerraContact Ag Silver salt
SilverDerm 7 Ionic silver
Silverlon Wound & Burn Contact Dressings Ionic silver
Therabond 3D with SilvertrakTM Technology Silver
Foams RTD Silver zirconium phosphate
Acticoat Moisture Control Elemental silver
Allevyn Ag Silver sulfadiazine
Aquacel Ag Ionic silver
Biatain Ag Adhesive Silver
HydraFoam/Ag Silver
MediPlus Comfort Border Foam Ag+ Silver
Mepilex Ag Silver
Optifoam Ag Adhesive Ionic silver
PolyMem MAX Silver Non-Adhesive
Dressing
Silver
Silverlon Negative Pressure Ionic silver
UrgoCell Silver/Cellosorb Ag Silver salts
V.A.C GranuFoam Silver Silver
Silverlon Acute Burn Glove Silver
Silvercel Elemental silver
Fibers/clothes/mats
/pads/others
Tegaderm Ag Mesh Dressing Silver sulfate
Absorbent Dermanet Ag+ Border Silver
Acticoat Elemental silver
Allevyn Ag Non-Adhesive Silver sulfadiazine
Durafiber Ag Ionic silver
Exsalt SD7 Silver
Antimicrobial Dressings for Improving Wound Healing
http://dx.doi.org/10.5772/63961
381
Dressing type Brand name Silver form
Gentell Calcium Alginate Ag Silver
Silverlon Calcium Alginate Silver
Simpurity Silver Alginate Pads Silver particles
Urgotul SSD Silver sulfadiazine
Vliwaktiv Ag Silver
Acticoat 7 Elemental silver
Arglaes film Silver
Films/meshes Avance Silver
Acticoat Absorbent Elemental silver
Algicell Ag Silver
Alginate based Algidex Ag Ionic silver
Biatain Alginate Ag Silver
CalciCare Silver zirconium
DermaGinate/Ag Silver
Dermanet Ag+ Silver
Maxorb ES Ag+ Silver
Maxorb Extra Ag+ Silver zirconium phosphate
McKesson Calcium Alginate
with Antimicrobial Silver
Silver
Opticell Ag+ Ionic silver
Restore Calcium Alginate Dressing
with Silver
Ionic silver
Sofsorb Ag Silver
Sorbalgon Ag Ionic silver
Suprasorb A + Ag Calcium Alginate Silver
Askina Calgitrol Ag Silver alginate
Invacare Silver Alginate Silver sodium hydrogen zirconium
phosphate
Melgisorb Ag Silver
SeaSorb Ag Ionic silver
Silvasorb Ionic silver
Sorbsan Silver Silver Sorbsan
Algidex Ag Ionic silver
Urgotul SSD/S.Ag Silver sulfadiazine
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Dressing type Brand name Silver form
Gauze Aquacel Ag Ionic silver
Arglaes Powder Silver
Hydrofiber Cardinal Health Hydrogel +Ag Silver
Powder DermaSyn/Ag Ionic silver
Hydrogel Elta Silver Gel Silver
ExcelGinate Ag Silver
Gentell Hydrogel Ag Silver sulfadiazine
SilvaSorb Antimicrobial Silver Dressing Ionic silver
Silver-Sept Silver Antimicrobial Skin &
Wound Gel
Silver
SilverMed Amorphous Hydrogel Silver
Silverseal Silver
SilvrSTAT Gel Silver nanoparticles
Viniferamine Hydrogel Ag Silver
Silverseal Silver oxide
Silver-Sept Antimicrobial Gel Silver salt
DermaCol Ag Collagen Matrix Silver
Puracol Plus Ag+ MicroScaffold Collagen Silver
Collagen based SilvaKollagen Gel Silver
Silverlon Adhesive Strips Silver
Contreet Hydrocolloid Silver
Adhesive strips Silverseal Hydrocolloid Silver
Hydrocolloid SilverMed Antimicrobial Wound Cleanser Silver microparticles
Table 2. List of selected commercially available antimicrobial silver-containing dressings [22, 102, 103].
3.3.2. Silver dressings in wound healing
AgNPs (∼11 to ∼12 nm) containing gelatin fiber mats were prepared by electrospinning
process and inhibited major microorganisms present in wounds [104]. Lin et al. [105] compared
silver-containing carbon-activated fibers with commercially available silver-containing
dressings and showed the silver-containing carbon-activated fibers to exhibit antibacterial
activity and biocompatibility and promoting granulation and collagen deposition. A novel
chitosan–hyaluronic acid composite with nanosilver was reported as a potential antimicrobial
wound healing dressing for diabetic foot ulcers possessing high porosity, swelling, water
uptake abilities, and biodegradable and potential blood clotting ability. The authors proved
the inhibitory effects on S. aureus, E. coli, MRSA, P. aeruginosa, and Klebsiella pneumoniae [106].
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In a related study, chitosan incorporated with polyphosphate and AgNPs was studied. The
polyphosphate acts as a procoagulant which boosts blood clotting, platelet adhesion, and
thrombin generation [107]. A similar scaffold dressing was developed by incorporating silver
nanoparticles with chitin and showed antibacterial and blood clotting activity [108]. In another
study, AgNPs containing hydrogel without any cytotoxicity but with antibacterial activity
were reported [109]. Various inorganic forms of silver including silver zeolite, silver zirconium
phosphate silicate, and silver zirconium phosphate demonstrate antimicrobial activity against
oral microorganisms [91]. Pant et al. [110] stated AgNPs containing nylon-6 nanofibers
prepared by one-step electrospinning process could be an effective antimicrobial wound
dressing to kill both Gram-negative E. coli and Gram-positive S. aureus. Archana et al. [111]
evaluated chitosan-blended polyvinyl pyrrolidone (PVP)–nano silver oxide (CPS) as an
effective wound dressing in vitro and in vivo.
Lansdown et al. [112] investigated two forms of silver-containing dressings (Contreet foam
and Contreet hydrocolloid) and found these promoted healing in chronic venous leg ulcers
and diabetic foot ulcers. Polyvinylpyrolidone and alginate-based hydrogel-containing
nanosilver has been functionally evaluated for efficient fluid handling capacity and strong
antimicrobial activity against all major microorganisms such as Pseudomonas, Staphylococcus,
Escherichia, and Candida [113]. Jodar et al. [114] demonstrated silver sulfadiazine-impregnated
hydrogel for antimicrobial topical application for wound healing. Silver sulfadiazine (SSD)-
impregnated hydrogel was prepared by polyvinyl alcohol (PVA) and dextran blending.
Boateng et al. [115] formulated an ideal lyophilized wafer dressing composed of alginate and
gelatin containing silver sulfadiazine for wound healing and showed the controlled release of
SSD over 7 h and expected to diminish microbial load in the wound area. A novel SSD-loaded
bilayer chitosan membrane was prepared with sustained release of silver which inhibits the
growth of P. aeruginosa and S. aureus [116]. Shanmugasundaram et al. [117] formulated SSD-
impregnated collagen-based scaffold with strong antibacterial activity in vitro. Ammons et al.
[118] formulated dressings by combining commercial silver dressings (ActicoatTM Absorbent,
Aquacel® Ag, and TegadermTMAg) with lactoferrin and xylitol and demonstrated greater
efficacy against MRSA and P. aeruginosa.
There are several clinical studies with silver-containing dressings in the treatment of infected
wounds to enhance wound healing, and the reader is referred to these [119–125].
3.4. Iodine and other antiseptics
Iodine is an old agent used in the treatment of chronic wounds and was used by soldiers during
wars. The antibacterial activity of iodine was first investigated by Davaine in 1880 [126]. Iodine
penetrates into the cell wall of microorganisms and damages the cell membrane by blocking
hydrogen bond. This phenomenon alters the structure and function of cell proteins and
enzymes, leading to cell death [127]. Iodine is active against a broad spectrum of microorgan-
isms including S. aureus, E. coli, Pseudomonas, Streptococcus, Salmonella, Candida, Enterobacter,
Klebsiella, Clostridium, Corynebacterium, and Mycobacterium [126]. Iodine dressings can be found
in two preparations as povidone iodine and cadexomer iodine, and the various commercial
formulations are summarized in Table 3.
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Polyhexamethylene biguanide (PHMB) is an another antiseptic and widely used as antimi-
crobial dressing in wound healing. PHMB is known to be effective against E. coli. S. aureus and
S. epidermidis. PHMB also works like iodine as it attaches to the bacterial cells and disrupts cell
membrane resulting in leakage of potassium ions and cytosolic components that lead to cell
death [128]. A study by Eberlein et al. [129] confirmed that PHMB containing biocellulose
wound dressings were more effective than silver-containing dressing in retarding microbial
loads present in locally infected wounds. Loke et al. [130] developed a two-layer dressing with
sustained release of chlorhexidine which showed activity against S. aureus and P. aeruginosa in
vitro.
Dressing type Product name Antiseptic
Pad Iodoflex 0.9% Cadexomer Iodine Pad Cadexomer iodine
Foam IodoFoam Iodine
Fibers Inadine Povidone iodine
Colloidal ointment base Braunovidon ointment/ointment gauze Povidone
Hydrogel dressing Iodozym Iodine
Liposome hydrogel Repithel Povidone
Foam Kerlix AMD PHMB
Sponges Telfa AMD PHMB
Foam Kendall AMD PHMB
Gauzes sponges Curity AMD Antimicrobial Gauze Sponges PHMB
Table 3. List of other commercially available antiseptics [36, 127].
3.5. Honey dressings
Honey has been used as wound dressing over centuries [131]. Honey has been reported in
several clinical studies for treating chronic diabetic foot ulcers [132–135] and has antimicrobial
and anti-inflammatory activity [136–138]. It is reported that honey can inhibit around 60
species of bacteria including Alcaligenes faecalis, Citrobacter freundii, E. coli, Enterobacter aerogenes,
Klebsiella pneumoniae, Mycobacterium phlei, Salmonella california, Salmonella enteritidis, Salmonella
typhimurium, Shigella sonnei, S. aureus, and Staphylococcus epidermidis [139]. In addition, it is
reported Manuka honey and Cameroonian honey have an effect on Pseudomonas aeruginosa,
methicillin-resistant S. aureus (MRSA), and vancomycin-resistant Enterococcus species [137,
140]. The antimicrobial properties of honey are ascribed to its low pH, hygroscopic nature, and
peroxide-containing compounds [141]. The rich contents of sugar in honey generate high
osmotic pressure and present an unsuitable environment to bacterial growth and cell
proliferation [139]. Van den Berg et al. [142] investigated the anti-inflammatory properties of
different types of honey in vitro by testing reactive oxygen species (ROS) inhibition capability
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and found American buckwheat honey exhibits high ROS inhibition ability. Many clinical
studies have been performed on the basis of the antimicrobial effect of honey [143–145]. Clinical
studies and bioactivity demonstrate the efficiency of honey in wound healing, maintaining a
moist environment, promoting drainage of wound exudate and autolytic debridement [144].
It has been reported in minimizing malodour and scar formation of the wound [145] as well
as angiogenic activity [146].
Sasikala et al. [147] developed a chitosan-based film dressing loaded with Manuka honey. They
identified chitosan–lactic acid with 6% honey showed ideal dressing properties in terms of
water vapor transmission rate, water absorption, tensile strength, elongation, and antibacterial
activity against E. coli and S. aureus. Table 4 summarizes the commercially available honey-
based dressings currently sold on the market.
Dressing type Product Name Honey type
Hydrocolloid MediHoney Leptospermum honey
Alginate-based MediHoney Leptospermum honey
Fibers MANUKAhd Manuka honey
Pure honey Surgihoney Bioengineered honey
Foam Ligasano Honeycomb
Pure honey MGO Manuka Honey Manuka honey
Sterile Manuka honey ManukaFill Manuka honey
Honey-impregnated gauze Manuka IG Manuka honey
Sheets, ribbon, gel TheraHoney Manuka honey
Knitted viscose mesh dressing, pure honey Activon Manuka honey
Alginate ribbon and dressing Algivon Manuka honey
Composite, foam/silicone dressings Actilite Manuka honey
Nonadherent gauze fibers MelDra Buckwheat honey
Table 4. List of selected commercially available honey dressings used in wound healing [22, 148, 149].
3.6. Polymer-based antimicrobial dressings
Natural and synthetic polymers are widely used in acute and chronic wound healing due to
their biodegradability, biocompatibility, and wound exudate handling capacity. However,
some polymers themselves have an antimicrobial activity [150]. The combination of polymers
and antimicrobial drugs provides effective dressings to improve wound healing. Biazar et al.
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[151] evaluated a synthetic polymer-based hydrogel dressing that exhibits biocompatible and
antimicrobials activity. In another study, synthetic polyvinyl alcohol was blended with calcium
alginate to produce nano fiber matrix by electrospinning technique. In vitro antibacterial test
showed the rate of inhibition of S. aureus depends on the concentration of calcium alginate
[152]. Chitosan is a cationic polymer whose positive charge interacts with a negative charge of
the microbial cell membrane, resulting in disruption and agglutination [153]. Carboxymethyl
chitosan has been reported as a broad spectrum antibiofilm agent which can prevent biofilm
formation for E. coli and S. aureus by 81.6 and 74.6%, respectively [154].
4. Summary
In this chapter, wound healing processes and types of dressings incorporating antimicrobial
agents have been briefly discussed. Antimicrobials loaded into dressings for direct application
to infected wound sites are becoming more popular worldwide in terms of safety, efficacy, cost
effective, and convenience. The key antimicrobial agents ranging from antiseptics such as
iodine, metals such as silver, antibiotics such as cephalosporins and aminoglycosides as well
as natural products such as honey have been covered. In addition, the driving forces behind
the developing of advanced therapeutic dressings have been reviewed. Furthermore, this
review has demonstrated different and wide range of antimicrobial-loaded dressings, and a
few clinical studies and commercially available antimicrobial dressings have been highlighted.
Given the wide range of scientific studies and commercial products publicly available, it is
evident that more evidence-based clinical trials are required to select appropriate dressings
for the patients. It is also important to note the interdisciplinary fields (including formulation
technology, biopharmaceutics, microbiology, materials and polymer chemistry and molecular
biology) required for developing an effective antimicrobial dressing able to treat infection and
also contribute towards enhanced wound healing.
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